Chromatin Acetylation, Memory, and LTP Are Impaired in CBP+/− Mice
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Alarcón, Juan MMalleret, Gaël
Touzani, Khalid
Vronskaya, Svetlana
Ishii, Shunsuke
Kandel, Eric R
Barco, Angel
Journal title
NeuronDate Published
2004-06Publication Volume
42Publication Issue
6Publication Begin page
947Publication End page
959
Metadata
Show full item recordAbstract
We studied a mouse model of the haploinsufficiency form of Rubinstein-Taybi syndrome (RTS), an inheritable disorder caused by mutations in the gene encoding the CREB binding protein (CBP) and characterized by mental retardation and skeletal abnormalities. In these mice, chromatin acetylation, some forms of long-term memory, and the late phase of hippocampal long-term potentiation (L-LTP) were impaired. We ameliorated the L-LTP deficit in two ways: (1) by enhancing the expression of CREB-dependent genes, and (2) by inhibiting histone deacetyltransferase activity (HDAC), the molecular counterpart of the histone acetylation function of CBP. Inhibition of HDAC also reversed the memory defect observed in fear conditioning. These findings suggest that some of the cognitive and physiological deficits observed on RTS are not simply due to the reduction of CBP during development but may also result from the continued requirement throughout life for both the CREB co-activation and the histone acetylation function of CBP.Citation
Alarcón JM, Malleret G, Touzani K, Vronskaya S, Ishii S, Kandel ER, Barco A. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron. 2004 Jun 24;42(6):947-59. doi: 10.1016/j.neuron.2004.05.021. PMID: 15207239.DOI
10.1016/j.neuron.2004.05.021ae974a485f413a2113503eed53cd6c53
10.1016/j.neuron.2004.05.021
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.
- Authors: Wood MA, Kaplan MP, Park A, Blanchard EJ, Oliveira AM, Lombardi TL, Abel T
- Issue date: 2005 Mar-Apr
- A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4.
- Authors: Bourtchouladze R, Lidge R, Catapano R, Stanley J, Gossweiler S, Romashko D, Scott R, Tully T
- Issue date: 2003 Sep 2
- Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.
- Authors: Zheng F, Kasper LH, Bedford DC, Lerach S, Teubner BJ, Brindle PK
- Issue date: 2016
- Simulations suggest pharmacological methods for rescuing long-term potentiation.
- Authors: Smolen P, Baxter DA, Byrne JH
- Issue date: 2014 Nov 7
- Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability.
- Authors: Valor LM, Pulopulos MM, Jimenez-Minchan M, Olivares R, Lutz B, Barco A
- Issue date: 2011 Feb 2